Global Single Cell Omics Market is currently valued at USD 4 billion and is estimated to grow at a CAGR of 24.9% in the forecasted period. The forecasted revenue hints at a growth of around 18.98 billion USD by 2030. The single cell omics deals with the profiling of single cells sampled from heterogeneous population of cells from different cellular states. Single cell omics has garnered enough interests recently because of its high application in drug discovery and research especially oncology. The market is governed by many players like 10X genomics and Bio – Rad laboratories and each have their own competitive advantage that has helped them earn a share in this competitive market. Entry barriers are often very high in such a niche market like Single cell omics and is dominated by the established players. Although, due to recent development in research and occurrence of pandemic the global interest has shifted towards this market which is clearly evident because of an increase in investments throughout all the companies in the single cell omics market. Along with investments, profits are increasing because of new developments in R&D and emergence of new technologies which are revolutionising the single cell market significantly.To know about the Research Methodology :- Request Free Sample Report
Single Cell Omics Market Dynamics
Driving huge opportunities High investments in R&D and huge development in technology have opened opportunities for single cell omics, along with significant players entering single cell omics market are 10X genomics, Illumina, etc. The market is enjoying a healthy growth because of new technologies like 3rd generation sequencing and NGS which are highly used because of higher demand and varied number of users across globe. Along with it, research institutes and clinical laboratories have worked effectively on single cell omics market to understand and experiment on new samples and gather some sustainable solutions towards recurring problems – Example: Detection of CTCs (Circulating Tumour cells) in liquid biopsies and multi-omics approach is the cellular indexing of epitopes. Thus, it has paved way for new opportunities in this existing competitive market. Recently, Bio.Inc launched Mission Bio Tapestri Single Cell Multi Omics Solution. The company also partnered with BioLegend to develop antibody panels for single cell detection. Its increasing use in immunology has also helped single cell omics industry gain attention during the tough times of pandemic especially when developed countries like US and China have faced the wraths of the virus. Also, Cellenion and SCIENION launched the cellenCHIP 384 for single-cell omics sample preparation. The cellenCHIP 384, with its nano well format, provides options for customization and also provide maximum output. In October 2022, BioSkryb Genomics announced an agreement with Cooper Genomics to license BioSkryb’s patented genomic amplification technology. Cooper Genomics will use the technology by BioSkryb to improve their preimplantation genetic testing (PGT) abilities and allow clinicians and researchers to unlock deeper understandings of the genome to evaluate embryonic viability. As research has developed, it has provided inroads into the market which is because of higher market share and increased capacity to spend. The market is forecasted to increase more than 10 billion till the year 2030, reflecting how the future technologies in the single cell omics industry are going to unfurl. Challenges need to be tackled Sample preparation and cell reproducibility are the common challenge which often makes this market complex. High infrastructure cost - as the technologies, databases and the equipment are very expensive to buy. Thus, it creates a huge entry barrier for newly started companies to compete with market leaders. The expense of equipment and technology can only be justified if the experts using them are available, which is again an important challenge when it comes to Single cell omics market. Clinical regulations in application of single cell omics are of abundant importance and can create complexity in the entire process. Standardization of protocols is considered a huge constraint in analysis, which can make it difficult to compare results across different studies. This can also limit the reproducibility and validity of findings causing troubles in analysing complex and intricate data. Single cell omics market trendsSuch trends are governing the future of the Single cell omics industry, but along with these trends – Higher investments from governments like Singapore government (GIS) and also from other private financial institutions has created a huge cash flow in the market, which has attracted many companies to diverge their interests into the single cell omics industry indicating a huge success for the market across the globe. Cardiovascular research, IVF and cancer treatment – all have ushered new opportunities for Single cell omics companies. Also increasing interest in immunology and single cell omics and its application in drugs and treatments has also resulted in increased demand which will further indicate where the market will head in few years times.
High throughput platforms and emerging technologies Advances in microfluidics and automation are making sure that the market moves ahead with technologies like automatic cell type identification (Cell type annotation) Multiomics approaches are increasing Cellular indexing of transcriptomes and epitopes by sequencing are future trends in market Spatial omics is emerging The characterization of gene expression and other molecular features in their native tissue context Data analysis tool to simplify the complex data Drop-seq, InDrop, and 10X Chromium are well-known platforms useful for market Single-cell imaging Microscopy techniques that enable the collection of separate data from individual cells Single Cell Omics Market Segment Analysis
Based on Technology, Cell isolation technologies mainly consist of 2 factors - Flow cytometry and Selective single cell isolation. Cell isolation techniques based on flow cytometry such as fluorescence activated cell sorting (FACS) or magnetic activated cell sorting (MACS) distinguish cells according to their fluorescence or magnetic labelling. The annual growth for the single cell omics has been nearly 8% annually because of increase in diagnosis of various diseases such as cancer and HIV. Sample preparation technologies are: Dielectrophoretic digital sorting, enzymatic digestion, FACS, hydrodynamic traps, laser capture microdissection, manual picking, microfluidics and micromanipulation are some sample preparation technologies Analysis of next-generation sequencing - NGS is an emerging technology to determine DNA/RNA sequences for whole genome or specific regions The key steps for NGS data analysis are cleaning, data exploration, visualization, and deepening. Based on Type, Single cell genomics can be applied in diagnosis of clinical diseases and also huge advancements in healthcare especially in liquid biopsies have paved a bigger path for this single cell omics market. Overall, the genomics market has taken a huge rise, up to 25% post pandemic, showing a growing market in itself. Thus, single cell genomics become an important type. Proteomics itself is a huge market currently valued 45.6 billion USD, and single cell proteomics in nearly 3.5 billion USD. Thus, annual growth rate of this type is forecasted at around 15% showing huge opportunities. Its importance in biomarker characterisation and advance immunotherapies has helped the market grow rapidly. Transcriptomics focuses on gene expression pattern and measures RNA concentration of multiple genes. Also, single cell transcriptomics has a huge scope in future because of increased investments and better facilities for R&D. Metabolomics provides the basis of biochemical heterogeneity and has the least market share amongst its type because of the rapid metabolome shift, and differences in metabolite structuresBased on Application, Oncology – Applications in oncology have been one of the most prominent areas of growth. Single-cell multi-omics (scMulti-omics) has brought transformative insights into immuno-oncology, making it a huge success in describing immune subsets and defining important regulators of antitumor immunology. Also increased research on cancer therapy has opened new doors for applications in oncology. Cell biology presents a huge scope for this single cell omics market as Single-cell RNA sequencing, can provide a wealth of information about the gene expression patterns and signalling pathways within individual cells. Neurology is a growing application in single cell omics market as it has the potential to provide a deeper understanding of the molecular mechanisms underlying neurological disorders and their treatments. Example - Researchers can use single-cell RNA sequencing to identify subtypes of neurons or glial cells in the brain Immunology is a growing field if we consider single cell omics and immunology together. Various experiments and models have started using omics in immunology thus creating opportunities for the future
Based on End user, The single cell omics market can be classified based on its End user - pharmaceutical and biotechnology companies, academic research institutes, and clinical laboratories. The pharmaceutical companies have an established market and thus show a good market share because of its high requirements. Clinical laboratories are also increasing because of high investments in the field. While academic institutes are enjoying a larger market share Based on region, The Single cell omics market can be classified based on its regions – North America, Asia – Pacific, Middle East and Africa, Europe and South America. North America is the dominant player in the Single cell omics industry where it nearly caters to 37% of the entire market. Asia Pacific, is the growing market because of high investments in research and development especially after the pandemic. Europe is also predominant because of its core players like Germany and Switzerland who are holding high market share in the Single cell omics market and are just ahead of Asia Pacific. The estimations are that Asia Pacific will surpass Europe in market share because of recent developments in Asia Pacific. While South America and Middle eastern countries are also slowly increasing its market share due to increasing investments.
Single Cell Omics Market Regional Insights
Globally the market is spread across all the continents, where North America and Europe have been the leaders in terms of revenue because of high investments. The United States, in particular, has a significant share in the single cell omics market due to the presence of a large number of biotechnology and pharmaceutical companies, academic research institutes, and government initiatives promoting single cell omics research. Also, the presence of advanced healthcare infrastructure and the availability of funding for research and development has contributed to the growth of the single cell omics market in the United States. The US is one of the leading countries in terms of revenue and market share of the single cell omics industry. The US has well-established facilities with adequate advancement in technologies to work on protein sequencing. While Canada is just falling behind the US, it has taken significant measures to replicate the success of its neighbour. Canada has strong life sciences sector and is also home to a growing number of research institutions and biotechnology companies that are actively involved in Single cell omics research which they are leveraging to increase their market share. Also, with increasing focus on drugs and therapies have made Mexico gain some market share as well. The market in Asia Pacific is significantly showing rapid growth which is a result of a huge population and strong governmental support like Singapore government, which has made it possible for Asia Pacific to clock the highest growth rate across the globe. Other crucial factors have been the need of personalized medicine and targeted therapies, which rely on single cell omics technologies along with collaborations with industries to provide sustainable solutions. Europe is another dominant player in the market, where Germany, France, Switzerland and UK lead the way in the Single cell omics market. The intact healthcare market and growing investments have helped Europe dominate this industry. Collaborations like Horizon 2020 and European Molecular Biology Laboratory (EMBL) have helped Europe flourish in this single cell omics market. Europe stands behind US and has 2nd largest market share amongst the classified regions. The Single cell omics market in South America is growing steadily, and Brazil and Argentina are emerging as the dominant players. Both countries have spent huge amounts of dollars to sustain this Single cell omics market. Huge demand and established facilities have helped Brazil and Argentina gain a good share of the market in this industry. Along with these two, even Chile, and Peru are emerging markets that have the potential to compete with the two main players of the South American continent The Single cell omics market is still in the early stages for both regions. Traditionally, Middle eastern region and African parts lack adequate infrastructure and proficiency. Recently the Middle East has increased its focus on biotechnology and research which will give the country a boost in this sector. Some collaborations with research institute like Dubai Future Foundation have provided opportunities for its researchers to excel in this field. Other countries in this region, such as Egypt, South Africa, and Morocco, are also expected to contribute to the growth of the Single cell omics market in the coming years.Single Cell Omics Market Competitive Landscape:
The single cell omics market is competitive with oligopoly of some nations like US and Germany. There are many private companies who are given a boost by the governments itself to excel in their applications. But at the same time, increased demand and awareness on importance of genomics and single cell analysis has opened new opportunities for many players to enter the single cell omics market like BioTuring and Mission Bio. The single cell omics market has developed since 2000s and with technological advancements and investment in research, the single cell omics market is ready to flourish. Main players in the market are American companies like Illumina (provides NovaSeq 6000 and NextSeq 550D sequencers) and 10X Genomics (provides chromium single cell gene expression and Immune profiling system). who have captured significant market share. Other dominant companies are from Canada, Germany, UK who are enjoying a healthy percent of share of the single cell omics market. Takara Bio provides the Smart-Seq2 protocol for single-cell transcriptome analysis. Thus, each company offers some products or services, which becomes a distinguishable factor between competitors The pandemic has led to an increased focus on vaccine development, which has driven demand for single cell omics products and services. Single cell omics technologies, such as single-cell RNA sequencing, have been used to study the immune response to the virus. Thus, post pandemic demand has increased significantly and to counter this demand, the single cell omics market has offered many competitors, the opportunity to excel in single cell omics industry. Thus, collaborations and guidance have been a crucial part of this progress. Example- Illumina and Bio-Rad collaborated together (Bio-Rad's Droplet Digital technology with Illumina's NextSeq sequencing system.)Single Cell Omics Market Scope: Inquire before buying
Single Cell Omics Market Report Coverage Details Base Year: 2023 Forecast Period: 2024-2030 Historical Data: 2018 to 2023 Market Size in 2023: USD 4 Bn. Forecast Period 2024 to 2030 CAGR: 24.9% Market Size in 2030: USD 18.98 Bn. Segments Covered: by Application Oncology Neurology Immunology Cell Biology by Technology Cell isolation technologies Sample preparation technologies Analysis of next-generation sequencing by Type Genomics Transcriptomics Metabolomics Proteomics by End - User Pharma companies Research institutions Clinical Laboratories Single Cell Omics Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Single Cell Omics Market Key Players
1. 10x Genomics (US) 2. Illumina (US) 3. Bio-Techne (US) 4. Onramp Bioinformatics (US) 5. ACGT: (South Africa) 6. Vizgen Biosciences (US) 7. 10x Genomics (US) 8. Fluidigm (US) 9. Mission Bio (US) 10.Becton, Dickinson and Company (US) 11.NuGEN Technologies (US) 12.WaferGen Biosystems (US) 13.Agilent Technologies (US) 14.GenapSys (US) 15.Bio-Rad Laboratories (US) 16.Genosha: (Chile) 17.SiMMo3D: (Brazil) 18.Takara Bio (Japan) 19.Oxford Nanopore Technologies (UK) 20.Dolomite Bio (UK) 21.QIAGEN (Netherlands) 22.CytoSMART Technologies (Netherlands) 23.Takara Bio (Japan) 24.OriGen Biomedical: (UAE) 25.Saudi Biosciences: (Saudi Arabia) FAQ Q.1) What is the CAGR of Single cell omics market? Ans: The CAGR forecast for the single cell omics market is 24.9% Q.2) Which are the leading companies in single cell omics market? Ans: Illumina, 10X genomics, Takara Bio are some of the leading companies in the Q.3) What are the current trends in single cell omics industry? Ans: The current trends are focused on – Multiomics, Spatial omics and Drop-seq(like tools to analyse complex data) Q.4) Which is the leading region in single cell omics market? Ans: North America leads the market of market significantly Q.5) What was the forecasted period of this report? Ans: The forecast period is from 2024 – 2030.
1. Single cell omics Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Single cell omics Market: Dynamics 2.1. Single cell omics Market Trends by Region 2.1.1. North America Single cell omics Market Trends 2.1.2. Europe Single cell omics Market Trends 2.1.3. Asia Pacific Single cell omics Market Trends 2.1.4. Middle East and Africa Single cell omics Market Trends 2.1.5. South America Single cell omics Market Trends 2.2. Single cell omics Market Dynamics by Region 2.2.1. North America 2.2.1.1. North America Single cell omics Market Drivers 2.2.1.2. North America Single cell omics Market Restraints 2.2.1.3. North America Single cell omics Market Opportunities 2.2.1.4. North America Single cell omics Market Challenges 2.2.2. Europe 2.2.2.1. Europe Single cell omics Market Drivers 2.2.2.2. Europe Single cell omics Market Restraints 2.2.2.3. Europe Single cell omics Market Opportunities 2.2.2.4. Europe Single cell omics Market Challenges 2.2.3. Asia Pacific 2.2.3.1. Asia Pacific Single cell omics Market Drivers 2.2.3.2. Asia Pacific Single cell omics Market Restraints 2.2.3.3. Asia Pacific Single cell omics Market Opportunities 2.2.3.4. Asia Pacific Single cell omics Market Challenges 2.2.4. Middle East and Africa 2.2.4.1. Middle East and Africa Single cell omics Market Drivers 2.2.4.2. Middle East and Africa Single cell omics Market Restraints 2.2.4.3. Middle East and Africa Single cell omics Market Opportunities 2.2.4.4. Middle East and Africa Single cell omics Market Challenges 2.2.5. South America 2.2.5.1. South America Single cell omics Market Drivers 2.2.5.2. South America Single cell omics Market Restraints 2.2.5.3. South America Single cell omics Market Opportunities 2.2.5.4. South America Single cell omics Market Challenges 2.3. PORTER’s Five Forces Analysis 2.4. PESTLE Analysis 2.5. Technology Roadmap 2.6. Regulatory Landscape by Region 2.6.1. North America 2.6.2. Europe 2.6.3. Asia Pacific 2.6.4. Middle East and Africa 2.6.5. South America 2.7. Key Opinion Leader Analysis For Single cell omics Industry 2.8. Analysis of Government Schemes and Initiatives For Single cell omics Industry 2.9. Single cell omics Market Trade Analysis 2.10. The Global Pandemic Impact on Single cell omics Market 3. Single cell omics Market: Global Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million) 2023-2030 3.1. Single cell omics Market Size and Forecast, by Application (2023-2030) 3.1.1. Oncology 3.1.2. Neurology 3.1.3. Immunology 3.1.4. Cell Biology 3.2. Single cell omics Market Size and Forecast, by Technology (2023-2030) 3.2.1. Cell isolation technologies 3.2.2. Sample preparation technologies 3.2.3. Analysis of next-generation sequencing 3.3. Single cell omics Market Size and Forecast, by Type (2023-2030) 3.3.1. Genomics 3.3.2. Transcriptomics 3.3.3. Metabolomics 3.3.4. Proteomics 3.4. Single cell omics Market Size and Forecast, by End - User (2023-2030) 3.4.1. Pharma companies 3.4.2. Research institutions 3.4.3. Clinical Laboratories 3.5. Single cell omics Market Size and Forecast, by Region (2023-2030) 3.5.1. North America 3.5.2. Europe 3.5.3. Asia Pacific 3.5.4. Middle East and Africa 3.5.5. South America 4. North America Single cell omics Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 4.1. North America Single cell omics Market Size and Forecast, by Application (2023-2030) 4.1.1. Oncology 4.1.2. Neurology 4.1.3. Immunology 4.1.4. Cell Biology 4.2. North America Single cell omics Market Size and Forecast, by Technology (2023-2030) 4.2.1. Cell isolation technologies 4.2.2. Sample preparation technologies 4.2.3. Analysis of next-generation sequencing 4.3. North America Single cell omics Market Size and Forecast, by Type (2023-2030) 4.3.1. Genomics 4.3.2. Transcriptomics 4.3.3. Metabolomics 4.3.4. Proteomics 4.4. North America Single cell omics Market Size and Forecast, by End - User (2023-2030) 4.4.1. Pharma companies 4.4.2. Research institutions 4.4.3. Clinical Laboratories 4.5. North America Single cell omics Market Size and Forecast, by Country (2023-2030) 4.5.1. United States 4.5.1.1. United States Single cell omics Market Size and Forecast, by Application (2023-2030) 4.5.1.1.1. Oncology 4.5.1.1.2. Neurology 4.5.1.1.3. Immunology 4.5.1.1.4. Cell Biology 4.5.1.2. United States Single cell omics Market Size and Forecast, by Technology (2023-2030) 4.5.1.2.1. Cell isolation technologies 4.5.1.2.2. Sample preparation technologies 4.5.1.2.3. Analysis of next-generation sequencing 4.5.1.3. United States Single cell omics Market Size and Forecast, by Type (2023-2030) 4.5.1.3.1. Genomics 4.5.1.3.2. Transcriptomics 4.5.1.3.3. Metabolomics 4.5.1.3.4. Proteomics 4.5.1.4. United States Single cell omics Market Size and Forecast, by End - User (2023-2030) 4.5.1.4.1. Pharma companies 4.5.1.4.2. Research institutions 4.5.1.4.3. Clinical Laboratories 4.5.2. Canada 4.5.2.1. Canada Single cell omics Market Size and Forecast, by Application (2023-2030) 4.5.2.1.1. Oncology 4.5.2.1.2. Neurology 4.5.2.1.3. Immunology 4.5.2.1.4. Cell Biology 4.5.2.2. Canada Single cell omics Market Size and Forecast, by Technology (2023-2030) 4.5.2.2.1. Cell isolation technologies 4.5.2.2.2. Sample preparation technologies 4.5.2.2.3. Analysis of next-generation sequencing 4.5.2.3. Canada Single cell omics Market Size and Forecast, by Type (2023-2030) 4.5.2.3.1. Genomics 4.5.2.3.2. Transcriptomics 4.5.2.3.3. Metabolomics 4.5.2.3.4. Proteomics 4.5.2.4. Canada Single cell omics Market Size and Forecast, by End - User (2023-2030) 4.5.2.4.1. Pharma companies 4.5.2.4.2. Research institutions 4.5.2.4.3. Clinical Laboratories 4.5.3. Mexico 4.5.3.1. Mexico Single cell omics Market Size and Forecast, by Application (2023-2030) 4.5.3.1.1. Oncology 4.5.3.1.2. Neurology 4.5.3.1.3. Immunology 4.5.3.1.4. Cell Biology 4.5.3.2. Mexico Single cell omics Market Size and Forecast, by Technology (2023-2030) 4.5.3.2.1. Cell isolation technologies 4.5.3.2.2. Sample preparation technologies 4.5.3.2.3. Analysis of next-generation sequencing 4.5.3.3. Mexico Single cell omics Market Size and Forecast, by Type (2023-2030) 4.5.3.3.1. Genomics 4.5.3.3.2. Transcriptomics 4.5.3.3.3. Metabolomics 4.5.3.3.4. Proteomics 4.5.3.4. Mexico Single cell omics Market Size and Forecast, by End - User (2023-2030) 4.5.3.4.1. Pharma companies 4.5.3.4.2. Research institutions 4.5.3.4.3. Clinical Laboratories 5. Europe Single cell omics Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 5.1. Europe Single cell omics Market Size and Forecast, by Application (2023-2030) 5.1. Europe Single cell omics Market Size and Forecast, by Technology (2023-2030) 5.1. Europe Single cell omics Market Size and Forecast, by Type (2023-2030) 5.1. Europe Single cell omics Market Size and Forecast, by End - User (2023-2030) 5.5. Europe Single cell omics Market Size and Forecast, by Country (2023-2030) 5.5.1. United Kingdom 5.5.1.1. United Kingdom Single cell omics Market Size and Forecast, by Application (2023-2030) 5.5.1.2. United Kingdom Single cell omics Market Size and Forecast, by Technology (2023-2030) 5.5.1.3. United Kingdom Single cell omics Market Size and Forecast, by Type (2023-2030) 5.5.1.4. United Kingdom Single cell omics Market Size and Forecast, by End - User (2023-2030) 5.5.2. France 5.5.2.1. France Single cell omics Market Size and Forecast, by Application (2023-2030) 5.5.2.2. France Single cell omics Market Size and Forecast, by Technology (2023-2030) 5.5.2.3. France Single cell omics Market Size and Forecast, by Type (2023-2030) 5.5.2.4. France Single cell omics Market Size and Forecast, by End - User (2023-2030) 5.5.3. Germany 5.5.3.1. Germany Single cell omics Market Size and Forecast, by Application (2023-2030) 5.5.3.2. Germany Single cell omics Market Size and Forecast, by Technology (2023-2030) 5.5.3.3. Germany Single cell omics Market Size and Forecast, by Type (2023-2030) 5.5.3.4. Germany Single cell omics Market Size and Forecast, by End - User (2023-2030) 5.5.4. Italy 5.5.4.1. Italy Single cell omics Market Size and Forecast, by Application (2023-2030) 5.5.4.2. Italy Single cell omics Market Size and Forecast, by Technology (2023-2030) 5.5.4.3. Italy Single cell omics Market Size and Forecast, by Type (2023-2030) 5.5.4.4. Italy Single cell omics Market Size and Forecast, by End - User (2023-2030) 5.5.5. Spain 5.5.5.1. Spain Single cell omics Market Size and Forecast, by Application (2023-2030) 5.5.5.2. Spain Single cell omics Market Size and Forecast, by Technology (2023-2030) 5.5.5.3. Spain Single cell omics Market Size and Forecast, by Type (2023-2030) 5.5.5.4. Spain Single cell omics Market Size and Forecast, by End - User (2023-2030) 5.5.6. Sweden 5.5.6.1. Sweden Single cell omics Market Size and Forecast, by Application (2023-2030) 5.5.6.2. Sweden Single cell omics Market Size and Forecast, by Technology (2023-2030) 5.5.6.3. Sweden Single cell omics Market Size and Forecast, by Type (2023-2030) 5.5.6.4. Sweden Single cell omics Market Size and Forecast, by End - User (2023-2030) 5.5.7. Austria 5.5.7.1. Austria Single cell omics Market Size and Forecast, by Application (2023-2030) 5.5.7.2. Austria Single cell omics Market Size and Forecast, by Technology (2023-2030) 5.5.7.3. Austria Single cell omics Market Size and Forecast, by Type (2023-2030) 5.5.7.4. Austria Single cell omics Market Size and Forecast, by End - User (2023-2030) 5.5.8. Rest of Europe 5.5.8.1. Rest of Europe Single cell omics Market Size and Forecast, by Application (2023-2030) 5.5.8.2. Rest of Europe Single cell omics Market Size and Forecast, by Technology (2023-2030) 5.5.8.3. Rest of Europe Single cell omics Market Size and Forecast, by Type (2023-2030) 5.5.8.4. Rest of Europe Single cell omics Market Size and Forecast, by End - User (2023-2030) 6. Asia Pacific Single cell omics Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 6.1. Asia Pacific Single cell omics Market Size and Forecast, by Application (2023-2030) 6.2. Asia Pacific Single cell omics Market Size and Forecast, by Technology (2023-2030) 6.3. Asia Pacific Single cell omics Market Size and Forecast, by Type (2023-2030) 6.4. Asia Pacific Single cell omics Market Size and Forecast, by End - User (2023-2030) 6.5. Asia Pacific Single cell omics Market Size and Forecast, by Country (2023-2030) 6.5.1. China 6.5.1.1. China Single cell omics Market Size and Forecast, by Application (2023-2030) 6.5.1.2. China Single cell omics Market Size and Forecast, by Technology (2023-2030) 6.5.1.3. China Single cell omics Market Size and Forecast, by Type (2023-2030) 6.5.1.4. China Single cell omics Market Size and Forecast, by End - User (2023-2030) 6.5.2. S Korea 6.5.2.1. S Korea Single cell omics Market Size and Forecast, by Application (2023-2030) 6.5.2.2. S Korea Single cell omics Market Size and Forecast, by Technology (2023-2030) 6.5.2.3. S Korea Single cell omics Market Size and Forecast, by Type (2023-2030) 6.5.2.4. S Korea Single cell omics Market Size and Forecast, by End - User (2023-2030) 6.5.3. Japan 6.5.3.1. Japan Single cell omics Market Size and Forecast, by Application (2023-2030) 6.5.3.2. Japan Single cell omics Market Size and Forecast, by Technology (2023-2030) 6.5.3.3. Japan Single cell omics Market Size and Forecast, by Type (2023-2030) 6.5.3.4. Japan Single cell omics Market Size and Forecast, by End - User (2023-2030) 6.5.4. India 6.5.4.1. India Single cell omics Market Size and Forecast, by Application (2023-2030) 6.5.4.2. India Single cell omics Market Size and Forecast, by Technology (2023-2030) 6.5.4.3. India Single cell omics Market Size and Forecast, by Type (2023-2030) 6.5.4.4. India Single cell omics Market Size and Forecast, by End - User (2023-2030) 6.5.5. Australia 6.5.5.1. Australia Single cell omics Market Size and Forecast, by Application (2023-2030) 6.5.5.2. Australia Single cell omics Market Size and Forecast, by Technology (2023-2030) 6.5.5.3. Australia Single cell omics Market Size and Forecast, by Type (2023-2030) 6.5.5.4. Australia Single cell omics Market Size and Forecast, by End - User (2023-2030) 6.5.6. Indonesia 6.5.6.1. Indonesia Single cell omics Market Size and Forecast, by Application (2023-2030) 6.5.6.2. Indonesia Single cell omics Market Size and Forecast, by Technology (2023-2030) 6.5.6.3. Indonesia Single cell omics Market Size and Forecast, by Type (2023-2030) 6.5.6.4. Indonesia Single cell omics Market Size and Forecast, by End - User (2023-2030) 6.5.7. Malaysia 6.5.7.1. Malaysia Single cell omics Market Size and Forecast, by Application (2023-2030) 6.5.7.2. Malaysia Single cell omics Market Size and Forecast, by Technology (2023-2030) 6.5.7.3. Malaysia Single cell omics Market Size and Forecast, by Type (2023-2030) 6.5.7.4. Malaysia Single cell omics Market Size and Forecast, by End - User (2023-2030) 6.5.8. Vietnam 6.5.8.1. Vietnam Single cell omics Market Size and Forecast, by Application (2023-2030) 6.5.8.2. Vietnam Single cell omics Market Size and Forecast, by Technology (2023-2030) 6.5.8.3. Vietnam Single cell omics Market Size and Forecast, by Type (2023-2030) 6.5.8.4. Vietnam Single cell omics Market Size and Forecast, by End - User (2023-2030) 6.5.9. Taiwan 6.5.9.1. Taiwan Single cell omics Market Size and Forecast, by Application (2023-2030) 6.5.9.2. Taiwan Single cell omics Market Size and Forecast, by Technology (2023-2030) 6.5.9.3. Taiwan Single cell omics Market Size and Forecast, by Type (2023-2030) 6.5.9.4. Taiwan Single cell omics Market Size and Forecast, by End - User (2023-2030) 6.5.10. Rest of Asia Pacific 6.5.10.1. Rest of Asia Pacific Single cell omics Market Size and Forecast, by Application (2023-2030) 6.5.10.2. Rest of Asia Pacific Single cell omics Market Size and Forecast, by Technology (2023-2030) 6.5.10.3. Rest of Asia Pacific Single cell omics Market Size and Forecast, by Type (2023-2030) 6.5.10.4. Rest of Asia Pacific Single cell omics Market Size and Forecast, by End - User (2023-2030) 7. Middle East and Africa Single cell omics Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 7.1. Middle East and Africa Single cell omics Market Size and Forecast, by Application (2023-2030) 7.2. Middle East and Africa Single cell omics Market Size and Forecast, by Technology (2023-2030) 7.3. Middle East and Africa Single cell omics Market Size and Forecast, by Type (2023-2030) 7.4. Middle East and Africa Single cell omics Market Size and Forecast, by End - User (2023-2030) 7.5. Middle East and Africa Single cell omics Market Size and Forecast, by Country (2023-2030) 7.5.1. South Africa 7.5.1.1. South Africa Single cell omics Market Size and Forecast, by Application (2023-2030) 7.5.1.2. South Africa Single cell omics Market Size and Forecast, by Technology (2023-2030) 7.5.1.3. South Africa Single cell omics Market Size and Forecast, by Type (2023-2030) 7.5.1.4. South Africa Single cell omics Market Size and Forecast, by End - User (2023-2030) 7.5.2. GCC 7.5.2.1. GCC Single cell omics Market Size and Forecast, by Application (2023-2030) 7.5.2.2. GCC Single cell omics Market Size and Forecast, by Technology (2023-2030) 7.5.2.3. GCC Single cell omics Market Size and Forecast, by Type (2023-2030) 7.5.2.4. GCC Single cell omics Market Size and Forecast, by End - User (2023-2030) 7.5.3. Nigeria 7.5.3.1. Nigeria Single cell omics Market Size and Forecast, by Application (2023-2030) 7.5.3.2. Nigeria Single cell omics Market Size and Forecast, by Technology (2023-2030) 7.5.3.3. Nigeria Single cell omics Market Size and Forecast, by Type (2023-2030) 7.5.3.4. Nigeria Single cell omics Market Size and Forecast, by End - User (2023-2030) 7.5.4. Rest of ME&A 7.5.4.1. Rest of ME&A Single cell omics Market Size and Forecast, by Application (2023-2030) 7.5.4.2. Rest of ME&A Single cell omics Market Size and Forecast, by Technology (2023-2030) 7.5.4.3. Rest of ME&A Single cell omics Market Size and Forecast, by Type (2023-2030) 7.5.4.4. Rest of ME&A Single cell omics Market Size and Forecast, by End - User (2023-2030) 8. South America Single cell omics Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 8.1. South America Single cell omics Market Size and Forecast, by Application (2023-2030) 8.2. South America Single cell omics Market Size and Forecast, by Technology (2023-2030) 8.3. South America Single cell omics Market Size and Forecast, by Type(2023-2030) 8.4. South America Single cell omics Market Size and Forecast, by End - User (2023-2030) 8.5. South America Single cell omics Market Size and Forecast, by Country (2023-2030) 8.5.1. Brazil 8.5.1.1. Brazil Single cell omics Market Size and Forecast, by Application (2023-2030) 8.5.1.2. Brazil Single cell omics Market Size and Forecast, by Technology (2023-2030) 8.5.1.3. Brazil Single cell omics Market Size and Forecast, by Type (2023-2030) 8.5.1.4. Brazil Single cell omics Market Size and Forecast, by End - User (2023-2030) 8.5.2. Argentina 8.5.2.1. Argentina Single cell omics Market Size and Forecast, by Application (2023-2030) 8.5.2.2. Argentina Single cell omics Market Size and Forecast, by Technology (2023-2030) 8.5.2.3. Argentina Single cell omics Market Size and Forecast, by Type (2023-2030) 8.5.2.4. Argentina Single cell omics Market Size and Forecast, by End - User (2023-2030) 8.5.3. Rest Of South America 8.5.3.1. Rest Of South America Single cell omics Market Size and Forecast, by Application (2023-2030) 8.5.3.2. Rest Of South America Single cell omics Market Size and Forecast, by Technology (2023-2030) 8.5.3.3. Rest Of South America Single cell omics Market Size and Forecast, by Type (2023-2030) 8.5.3.4. Rest Of South America Single cell omics Market Size and Forecast, by End - User (2023-2030) 9. Global Single cell omics Market: Competitive Landscape 9.1. MMR Competition Matrix 9.2. Competitive Landscape 9.3. Key Players Benchmarking 9.3.1. Company Name 9.3.2. Business Segment 9.3.3. End-user Segment 9.3.4. Revenue (2023) 9.3.5. Company Locations 9.4. Leading Single cell omics Market Companies, by market capitalization 9.5. Market Structure 9.5.1. Market Leaders 9.5.2. Market Followers 9.5.3. Emerging Players 9.6. Mergers and Acquisitions Details 10. Company Profile: Key Players 10.1. 10x Genomics (US) 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Scale of Operation (small, medium, and large) 10.1.7. Details on Partnership 10.1.8. Regulatory Accreditations and Certifications Received by Them 10.1.9. Awards Received by the Firm 10.1.10. Recent Developments 10.2. Illumina (US) 10.3. Bio-Techne (US) 10.4. Onramp Bioinformatics (US) 10.5. ACGT: (South Africa) 10.6. Vizgen Biosciences (US) 10.7. 10x Genomics (US) 10.8. Fluidigm (US) 10.9. Mission Bio (US) 10.10. Becton, Dickinson and Company (US) 10.11. NuGEN Technologies (US) 10.12. WaferGen Biosystems (US) 10.13. Agilent Technologies (US) 10.14. GenapSys (US) 10.15. Bio-Rad Laboratories (US) 10.16. Genosha: (Chile) 10.17. SiMMo3D: (Brazil) 10.18. Takara Bio (Japan) 10.19. Oxford Nanopore Technologies (UK) 10.20. Dolomite Bio (UK) 10.21. QIAGEN (Netherlands) 10.22. CytoSMART Technologies (Netherlands) 10.23. Takara Bio (Japan) 10.24. OriGen Biomedical: (UAE) 10.25. Saudi Biosciences: (Saudi Arabia) 11. Key Findings 12. Industry Recommendations 13. Single cell omics Market: Research Methodology 14. Terms and Glossary